T. Rowe Price Investment Management Inc. Increases Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

T. Rowe Price Investment Management Inc. increased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,678,965 shares of the medical device company's stock after buying an additional 155,233 shares during the period. T. Rowe Price Investment Management Inc. owned 3.85% of Cooper Companies worth $705,928,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Byrne Asset Management LLC bought a new position in shares of Cooper Companies during the 4th quarter valued at $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies in the fourth quarter worth about $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies during the 4th quarter valued at about $38,000. Covestor Ltd grew its position in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after buying an additional 120 shares during the period. Finally, West Financial Advisors LLC bought a new stake in shares of Cooper Companies during the 4th quarter valued at $49,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 0.4 %

NASDAQ:COO traded up $0.29 during midday trading on Monday, reaching $81.18. 543,216 shares of the stock traded hands, compared to its average volume of 1,421,287. The stock has a market capitalization of $16.23 billion, a PE ratio of 41.64, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The business has a 50-day moving average of $82.13 and a two-hundred day moving average of $92.59.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on COO shares. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird lowered their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.